Evonik Industries Key Business Areas and Activities

Evonik Industries is a leading specialty chemicals company with a diverse portfolio of products and services. The company operates in three main business areas: Nutrition & Care, Performance Materials, and Specialty Additives.

The Nutrition & Care business area focuses on developing innovative solutions for the human nutrition and health markets, as well as for the cosmetics and personal care industry. Evonik's products in this area include amino acids, peptides, and lipids.

Evonik's Performance Materials business area is dedicated to developing innovative materials and solutions for various industries, including automotive, aerospace, and construction. The company's products in this area include polyurethane systems, foams, and coatings.

Evonik's Specialty Additives business area provides high-performance additives and functional materials for various industries, including coatings, adhesives, and construction materials.

Consider reading: Steward Health Care

Evonik Industries has a significant presence in the corporate lobbying scene, with a profile on OpenSecrets.org.

The company has expanded its production capacity in Mobile, Alabama, with its sodium methylate production facility now capable of producing up to 90,000 metric tons per year.

Here's an interesting read: Aker Floating Production

Evonik has also invested in an advanced biomaterials facility in Birmingham, Alabama, which will support global demand for its RESOMER-brand bioresorbable polymers.

The company's ownership structure is diverse, with 46% of the shares held by the RAG-Stiftung, a German foundation, and the remaining 54% held by individual investors in the form of streubesitz, or free float.

Here's a breakdown of the ownership structure as of June 11, 2024:

Evonik has also undergone a significant change in ownership in the past, with the British investment firm CVC Capital Partners selling its remaining 4.2% stake in the company in May 2016.

Evonik's ownership structure has undergone significant changes over the years. In June 2008, CVC Capital Partners acquired a 25.01% stake in the company for 2.4 billion euros.

The remaining shares were retained by the RAG-Stiftung, which initially planned to list Evonik on the stock exchange in 2012. However, due to market conditions, the IPO was postponed.

Since April 25, 2013, Evonik's shares have been traded on the Frankfurt Stock Exchange. Prior to the listing, institutional investors were given the opportunity to purchase around 14% of the shares for 2 billion euros.

The purchase price was 30 euros per share, but there was no official invitation to subscribe. CVC Capital Partners later sold its remaining 4.2% stake in Evonik in May 2016.

As of June 11, 2024, Evonik's share capital is divided into 466 million nennwertlose Namensaktien. The ownership structure is as follows:

This means that the RAG-Stiftung holds 46% of the company's shares, while the remaining 54% is held by institutional and individual investors.

Evonik has made a deliberate move to focus on its core business of special chemicals by selling off its previous investments in energy, real estate, and skin protection.

The company has successfully exited these non-core areas, allowing it to concentrate on its core strengths.

Evonik's strategic decision to divest these assets has likely helped streamline its operations and reduce financial liabilities.

By doing so, Evonik is now better positioned to allocate its resources towards driving growth and innovation in its special chemicals segment.

You might enjoy: Bengal Chemicals and Pharmaceuticals Limited

Evonik Industries has two major business areas: the Chemicals Business Area and Advanced Technologies.

The Chemicals Business Area is one of the world's largest producers of specialty chemicals, employing about 34,000 people. It includes six business units: Advanced Intermediates, Consumer Specialties, Coatings & Additives, Inorganic Materials, Health & Nutrition, and Performance Polymers.

The Chemicals Business Area has made significant investments in recent years, including the opening of a plant for the production of DL-methionine in Singapore, which was the largest investment to date in the company's history, costing €500 million.

See what others are reading: Mangalore Chemicals & Fertilizers

The Chemicals Business Area of Evonik is a giant in the industry, employing about 34,000 people and producing specialty chemicals on a massive scale.

It's one of the world's largest producers of specialty chemicals, and it's impressive to think about the scale of their operations.

This business area emerged from Evonik Degussa GmbH, which was formerly known as Degussa GmbH, a German company with a rich history dating back to the 19th century.

A unique perspective: Degussa Bank

The company has undergone significant changes over the years, including being acquired by RAG in 2006.

Their latest acquisition is the Tippecanoe Labs plant site at Lafayette, Indiana, which they acquired from Eli Lilly in 2010.

Evonik has also made significant investments in new facilities, such as the plant for the production of DL-methionine in Singapore, which was opened in November and cost a whopping €500 million.

This investment is a testament to the company's commitment to expanding its operations and staying ahead of the competition.

You might enjoy: Berdychiv Machine-building Plant

Evonik's Energy Business Area was a significant portion of the company, operated through Evonik Steag GmbH.

The company was the fifth largest power company in Germany, based in Essen.

Evonik Steag GmbH operated fourteen hard coal-fired power plants, with eleven located in Germany, and one in Turkey, one in Colombia, and one in the Philippines.

The company also operated two industrial power plants.

In addition to power generation, Evonik Steag GmbH was involved in the transport, processing, and distribution of hard coal, coke, and byproducts from coal processing.

They also provided gas supply, transport, and trading services.

In 2010, Evonik Industries signed an agreement to sell 51% of shares in its energy business to a consortium of municipal utilities in Germany's Rhine-Ruhr region.

The remaining 49% were acquired by the consortium for €570 million in August 2014.

Curious to learn more? Check out: One Swiss Bank

Evonik Industries has a dedicated Infrastructure segment, led by Thomas Wessel, which focuses on site-based infrastructure activities. This segment is a combination of the Business Lines Marl and Wesseling, as well as the Business Line Oxeno, a leading company in C4 chemistry.

The Business Lines Marl and Wesseling have successfully provided infrastructure services to both external and internal customers at their two multi-user sites. They have a high level of expertise in handling the complexity of the chemical business and the knowledge to operate it effectively.

Evonik Industries has divested its former holdings in energy and real estate, and now focuses on its core business of specialty chemicals.

If this caught your attention, see: Pacific International Lines

Evonik has streamlined its operations by divesting its former holdings in energy and real estate.

This strategic move allows the company to focus on its core business of specialty chemicals.

By concentrating on its core strengths, Evonik can optimize its resources and improve its overall efficiency.

Infrastructure plays a crucial role in the success of any business, and it's no exception for the company in question.

The segment Infrastructure, led by Thomas Wessel, brings together location-based infrastructure activities from the Business Lines Marl and Wesseling, and is complemented by the Business Line Oxeno, a leading company in C4 chemistry.

These Business Lines offer infrastructure services at two multi-user sites, successfully serving both external and internal customers.

The sites have a high level of expertise in handling the complexity of the business with chemistry, as well as the knowledge to operate it effectively.

Infrastructural services are provided by the Business Lines Marl and Wesseling at their respective sites, catering to both internal and external customers.

For more insights, see: Afcons Infrastructure

Evonik Industries has a strong presence in the world of sports sponsorship, particularly with Borussia Dortmund (BVB) in Germany's top football league.

Since the 2006/2007 season, Evonik has been the main sponsor of Borussia Dortmund, with the initial contract set to expire in 2013.

In 2012, Evonik extended its sponsorship deal with Borussia Dortmund until 2016, and again in 2014, this time until 2025.

Evonik's involvement with Borussia Dortmund goes beyond just sponsorship, as the company also holds a significant stake in the team's parent company, with 9.06% of the shares.

However, as of the 2020/21 season, Evonik is no longer the shirt sponsor for Borussia Dortmund in the Bundesliga.

To celebrate the team's new sponsor, Evonik, in 2007, over 50,000 season ticket holders received a free home jersey with the new logo.

A notable charitable effort by Evonik was a €1 million donation to a children's home in Japan that was destroyed by the 2011 Tohoku earthquake.

Here are some key sponsorship and partnership highlights for Evonik:

Evonik Industries has made a significant move in the Asian market by opening its first specialty chemical plant in Singapore. This strategic location allows the company to tap into the region's growing demand for high-quality chemicals.

The plant is designed to produce a wide range of specialty chemicals, including those used in the pharmaceutical, food, and cosmetics industries.

Evonik's investment in Singapore is a testament to the country's business-friendly environment and its commitment to innovation.

Readers also liked: Go-Ahead Singapore